Comparison of efficacy of rifaximin, probiotics and l-ornithine l-aspartate in overt hepatic encephalopathy: a randomized, phase IV, lactulose controlled clinical trial
Chinese Clinical Trial Registry ChiCTR2300075925, registered on 19 September 2023; ClinicalTrials.gov NCT07037394, registered on 24 June 2025. Released to the public on 26 June 2025.
Authors
- Shahid Muhammad Iqbal (ORCID: https://orcid.org/0000-0001-5746-0866)
- Muhammad Nauman Jamil
- Mohammed Aufy (ORCID: https://orcid.org/0000-0002-6693-4530)
- Jawad Akbar Khan (ORCID: https://orcid.org/0000-0002-6955-3282)
- QurratUlAin Jamil
- Atif Shahbaz
Institutions
- University of Vienna (AT)
- Islamia University of Bahawalpur (PK)
- Riphah International University (PK)
- University of Health Sciences Lahore (PK)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Trials
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1186/s13063-025-09173-2
- Citations
- 2
- Primary Topic
- Liver Disease and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Islamia University of Bahawalpur